• OPEN AN ACCOUNT
Indian Indices
Nifty
24,620.20 77.70
(0.32%)
Sensex
80,998.25 260.74
( 0.32%)
Bank Nifty
55,676.85 76.90
( 0.14%)
Nifty IT
36,938.10 123.20
( 0.33%)
Global Indices
Nasdaq
42,543.92 217.44
(0.51%)
Dow Jones
5,991.81 34.87
(0.59%)
Hang Seng
37,806.65 359.84
(0.96%)
Nikkei 225
8,787.02 12.76
(0.15%)
Forex
USD-INR
85.40 -0.14
(-0.17%)
EUR-INR
97.46 0.39
(0.40%)
GBP-INR
115.51 0.44
(0.39%)
JPY-INR
0.60 0.00
(0.58%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
276.1595271
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
89.69
8560.62
EPS(TTM)
Face Value()
Div & Yield %
9.76
1
0.11
 

Urja Global consolidated net profit declines 73.91% in the March 2025 quarter
May 21,2025
Net profit of Urja Global declined 73.91% to Rs 0.12 crore in the quarter ended March 2025 as against Rs 0.46 crore during the previous quarter ended March 2024. Sales rose 31.95% to Rs 17.18 crore in the quarter ended March 2025 as against Rs 13.02 crore during the previous quarter ended March 2024.

For the full year,net profit declined 37.75% to Rs 1.27 crore in the year ended March 2025 as against Rs 2.04 crore during the previous year ended March 2024. Sales rose 51.23% to Rs 67.25 crore in the year ended March 2025 as against Rs 44.47 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales17.1813.02 32 67.2544.47 51
OPM %4.131.69 -2.665.19 -
PBDT0.920.49 88 2.413.14 -23
PBT0.810.47 72 2.032.85 -29
NP0.120.46 -74 1.272.04 -38